1. Home
  2. WIMI vs IKNA Comparison

WIMI vs IKNA Comparison

Compare WIMI & IKNA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • WIMI
  • IKNA
  • Stock Information
  • Founded
  • WIMI 2015
  • IKNA 2016
  • Country
  • WIMI China
  • IKNA United States
  • Employees
  • WIMI N/A
  • IKNA N/A
  • Industry
  • WIMI Computer Software: Prepackaged Software
  • IKNA Biotechnology: Pharmaceutical Preparations
  • Sector
  • WIMI Technology
  • IKNA Health Care
  • Exchange
  • WIMI Nasdaq
  • IKNA Nasdaq
  • Market Cap
  • WIMI 94.3M
  • IKNA 81.6M
  • IPO Year
  • WIMI 2020
  • IKNA 2021
  • Fundamental
  • Price
  • WIMI $1.02
  • IKNA $1.49
  • Analyst Decision
  • WIMI
  • IKNA Buy
  • Analyst Count
  • WIMI 0
  • IKNA 2
  • Target Price
  • WIMI N/A
  • IKNA $3.00
  • AVG Volume (30 Days)
  • WIMI 4.3M
  • IKNA 169.0K
  • Earning Date
  • WIMI 01-01-0001
  • IKNA 03-11-2025
  • Dividend Yield
  • WIMI N/A
  • IKNA N/A
  • EPS Growth
  • WIMI N/A
  • IKNA N/A
  • EPS
  • WIMI N/A
  • IKNA N/A
  • Revenue
  • WIMI $84,137,968.00
  • IKNA $659,000.00
  • Revenue This Year
  • WIMI N/A
  • IKNA N/A
  • Revenue Next Year
  • WIMI N/A
  • IKNA N/A
  • P/E Ratio
  • WIMI N/A
  • IKNA N/A
  • Revenue Growth
  • WIMI 19.25
  • IKNA N/A
  • 52 Week Low
  • WIMI $0.63
  • IKNA $1.22
  • 52 Week High
  • WIMI $2.92
  • IKNA $1.94
  • Technical
  • Relative Strength Index (RSI)
  • WIMI 50.12
  • IKNA 48.35
  • Support Level
  • WIMI $0.86
  • IKNA $1.40
  • Resistance Level
  • WIMI $0.92
  • IKNA $1.60
  • Average True Range (ATR)
  • WIMI 0.07
  • IKNA 0.07
  • MACD
  • WIMI 0.01
  • IKNA 0.01
  • Stochastic Oscillator
  • WIMI 84.44
  • IKNA 47.62

About WIMI WiMi Hologram Cloud Inc.

WiMi Hologram Cloud Inc and its subsidiaries offer augmented reality (AR) based holographic services and products to cater to its customers. Its AR service and product offerings primarily consist of holographic AR advertising services and holographic AR entertainment products. It is also into the semiconductor business, in which the company provides central processing algorithm services and computer chip products to enterprise customers and the sales of comprehensive solutions for central processing algorithms and related services with software and hardware integration. The company reports in three segments: AR advertising, AR entertainment, and Semiconductor. Its geographical segments are Mainland China, Hong Kong, and International.

About IKNA Ikena Oncology Inc.

Ikena Oncology Inc is a targeted oncology company developing precision therapies for patients in need that target nodes of cancer growth, spread, and therapeutic resistance in the Hippo and RAS onco-signaling network. Its targeted oncology product candidate, IK-930, is an oral small-molecule inhibitor of the transcriptional enhanced associate domain, or TEAD, a transcription factor in the Hippo signaling pathway, a known oncogenic pathway that also drives resistance to multiple targeted and chemotherapies. Its other product candidates are IK-175 and IK-595.

Share on Social Networks: